FAC Explorer

Audit 321752

FY End
2023-12-31
Total Expended
$17.89M
Findings
0
Programs
11
Organization: Helio Health, Inc. and the Helio Health Foundation, Inc. (NY)
Year: 2023 Accepted: 2024-09-27
Auditor: Bonadio & CO LLP

Organization Exclusion Status:

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.959 Block Grants for Prevention and Treatment of Substance Abuse $7.90M Yes 0
14.267 Continuum of Care Program $4.67M - 0
93.958 Block Grants for Community Mental Health Services $1.86M Yes 0
93.696 Certified Community Behavioral Health Clinic Expansion Grants $1.11M Yes 0
93.788 Opioid Str $1.03M - 0
93.732 Mental and Behavioral Health Education and Training Grants $483,482 - 0
93.150 Projects for Assistance in Transition From Homelessness (path) $350,106 - 0
93.243 Substance Abuse and Mental Health Services Projects of Regional and National Significance $303,507 - 0
16.593 Residential Substance Abuse Treatment for State Prisoners $132,063 - 0
93.240 State Capacity Building $46,250 - 0
84.425 Education Stabilization Fund $6,868 - 0

Contacts

Name Title Type
KEJDTXXKAZ14 Jeffrey Justice Auditee
3154745506 Bettina Lipphardt Auditor
No contacts on file

Notes to SEFA

Title: GENERAL Accounting Policies: 1. GENERAL This schedule of expenditures of federal awards includes the federal grant activity of Helio Health, Inc. and Subsidiaries and is presented on the accrual basis of accounting. The information in this schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards. 2. INDIRECT COSTS Helio Health, Inc. and Subsidiaries elected to use the 10% de minimis rate as allowed under the Uniform Guidance. 3. SUBRECIPIENTS Helio Health, Inc. and Subsidiaries did not provide federal awards to subrecipients for the year ended December 31, 2023. De Minimis Rate Used: Y Rate Explanation: The auditee utilized the deminimis cost rate This schedule of expenditures of federal awards includes the federal grant activity of Helio Health, Inc. and Subsidiaries and is presented on the accrual basis of accounting. The information in this schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards.
Title: INDIRECT COSTS Accounting Policies: 1. GENERAL This schedule of expenditures of federal awards includes the federal grant activity of Helio Health, Inc. and Subsidiaries and is presented on the accrual basis of accounting. The information in this schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards. 2. INDIRECT COSTS Helio Health, Inc. and Subsidiaries elected to use the 10% de minimis rate as allowed under the Uniform Guidance. 3. SUBRECIPIENTS Helio Health, Inc. and Subsidiaries did not provide federal awards to subrecipients for the year ended December 31, 2023. De Minimis Rate Used: Y Rate Explanation: The auditee utilized the deminimis cost rate Helio Health, Inc. and Subsidiaries elected to use the 10% de minimis rate as allowed under the Uniform Guidance.
Title: SUBRECIPIENTS Accounting Policies: 1. GENERAL This schedule of expenditures of federal awards includes the federal grant activity of Helio Health, Inc. and Subsidiaries and is presented on the accrual basis of accounting. The information in this schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards. 2. INDIRECT COSTS Helio Health, Inc. and Subsidiaries elected to use the 10% de minimis rate as allowed under the Uniform Guidance. 3. SUBRECIPIENTS Helio Health, Inc. and Subsidiaries did not provide federal awards to subrecipients for the year ended December 31, 2023. De Minimis Rate Used: Y Rate Explanation: The auditee utilized the deminimis cost rate Helio Health, Inc. and Subsidiaries did not provide federal awards to subrecipients for the year ended December 31, 2023.